[1] |
Kerven C,Robinson S,Behnke R,et al.A pastoral frontier:From ehaos to eapitalism and the re-eolonisation of the Kazakh rangelands[J].J Arid Environ,2016,127:106-119.
|
[2] |
高成广,谢峰,冯亚东.生长抑素联合泮托拉唑治疗肝硬化合并上消化道出血的效果观察[J].临床肝胆病杂志,2016,32(2):284-287.
|
[3] |
匡美波.泮托拉唑与奥曲肽治疗消化性溃疡伴上消化道出血的临床观察[J].实用糖尿病杂志,2016,12(6):21-22.
|
[4] |
Zanten SVV,Henderson C,Hughes N.Patient satisfaetion with medieation for gastroesophageal reflux disease:a systematie review[J].Can J Gastroenterol,2016,26(4):196-204.
|
[5] |
邱博芸,章阳,韩思静.生长抑素联合泮托拉唑治疗急性上消化道出血及对患者血清超敏C反应蛋白的影响[J].标记免疫分析与临床,2017,24(7):786-788.
|
[6] |
路明房,南丽红.大剂量泮托拉唑联合奥曲肽在消化性溃疡并消化道出血中的应用[J].河南医学研究,2015,24(7):56-58.
|
[7] |
Sung J.Proton Pump Inhibitor Management in Bleeding Peptie Uleer Disease[J].Front Gastrointest Res,2013,32(1):68-76.
|
[8] |
Chen YL,Deng XL,Ping WU,et al.Study on nursing measures for Helieobaeterpylori infeetion-assoeiated aeute peptie uleer bleeding[J].Chin J Nosoeomiology,2013,23(24):5963-5965.
|
[9] |
Zed PJ,Loewen PS,Slavik RS,et al.Meta-analysis of proton pump inhibitors in treatment of bleeding peptie uleers[J].Ann Pharmaeother,2001,35(12):1528-1534.
|
[10] |
韦春秋.半剂量生长抑素联合泮托拉唑治疗急性胰腺炎的疗效评价[J].现代消化及介入诊疗,2016,21(1):47-49.
|
[11] |
李蕾蕾,李强,王宏,等.生长抑素联合埃索美拉唑治疗门静脉高压性上消化道出血[J].现代生物医学进展,2016,16(35):6939-6941.
|
[12] |
聂军,吴伟民.生长抑素与泮托拉唑联合凝血酶治疗急性上消化道出血的疗效分析[J].中国药房,2016,27(33):4656-4658.
|
[13] |
邹会.泮托拉唑联合枸橼酸铋钾在胃溃疡患者中的应用效果观察[J].中国当代医药,2017,24(13):146-148.
|
[14] |
蒲应香,邢成文,李玉鹏,等.血凝酶及生长抑素联合奥美拉唑治疗急性上消化道出血的临床疗效及安全性[J].中国中西医结合消化杂志,2016,21(2):150-152.
|
[15] |
Barkun AN,Herba K,Adam V,et al.The eost-effeetiveness of high-dose oral proton pump inhibition after endoseopy in the aeute treatment of peptie uleer bleeding[J].Aliment Pharmaeol Ther,2015,20(2):195-202.
|
[16] |
Wang CH,Ma HM,Chou HC,et al.High-Dose vs Non-High-Dose Proton Pump Inhibitors After Endoseopie Treatment in Patients With Bleeding Peptie Uleer:a Systematie Review and Meta-analysis of Randomized Controlled Trials[J].Areh Intern Med,2010,170(9):751.
|
[17] |
Oberg K,Kvols L,Caplin M,et al.Consensus report on the use of somatostatin analogs for the management of neuroendoerine tumors of the gastroenteropanereatie system[J].Ann Oneol,2004,15(6):966-973.
|